The clinical pharmacology of antineoplastic agents (first of two parts). 1975

B A Chabner, and C E Myers, and C N Coleman, and D G Johns

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine

Related Publications

B A Chabner, and C E Myers, and C N Coleman, and D G Johns
March 1977, The New England journal of medicine,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
July 1974, The New England journal of medicine,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
April 1977, The New England journal of medicine,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
July 1974, The New England journal of medicine,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
February 1986, Nihon rinsho. Japanese journal of clinical medicine,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
April 1994, Critical reviews in oncology/hematology,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
February 2012, European journal of clinical pharmacology,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
April 1980, The New England journal of medicine,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
February 1989, Seminars in oncology,
B A Chabner, and C E Myers, and C N Coleman, and D G Johns
January 1981, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!